Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317759512> ?p ?o ?g. }
- W4317759512 endingPage "3009" @default.
- W4317759512 startingPage "2979" @default.
- W4317759512 abstract "Soluble epoxide hydrolase (sEH) has been identified as an attractive target for anti-inflammatory drug design in recent years. Picomolar level compound G1 against sEH was obtained by introducing the hydrophilic group homopiperazine and hydrophobic fragment propionyl onto the structure of lead compound A. G1 showed good microsomal stability, a moderate plasma protein binding rate, and good oral bioavailability and was well tolerated in rats. G1 has significant analgesic effects on CFA-induced AIA mice, ameliorated the pancreatic injury in acute pancreatitis induced by l-arginine, reversed pancreatic injury, edema, and neutrophil infiltration, and increased the survival time of C57BL/6 mice in a lipopolysaccharide (LPS)-induced sepsis model. Moreover the expression levels of sEH, COX-2, NOS-2, vascular cell adhesion molecule (VCAM), IL-6, MCP-5, and tumor necrosis factor α (TNF-α) were measured by Western blot or enzyme-linked immunosorbent assay (ELISA), with varying degrees of decrease. These results suggested that G1 is a drug candidate worthy of further evaluation for the treatment of inflammation-induced diseases such as arthritis, acute pancreatitis, and sepsis." @default.
- W4317759512 created "2023-01-23" @default.
- W4317759512 creator A5013909385 @default.
- W4317759512 creator A5023065706 @default.
- W4317759512 creator A5026538320 @default.
- W4317759512 creator A5039078374 @default.
- W4317759512 creator A5046632856 @default.
- W4317759512 creator A5056064654 @default.
- W4317759512 creator A5056625293 @default.
- W4317759512 creator A5065595626 @default.
- W4317759512 creator A5071074966 @default.
- W4317759512 creator A5082785833 @default.
- W4317759512 creator A5087023556 @default.
- W4317759512 creator A5090244756 @default.
- W4317759512 date "2023-01-23" @default.
- W4317759512 modified "2023-10-14" @default.
- W4317759512 title "Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases" @default.
- W4317759512 cites W1535223882 @default.
- W4317759512 cites W1589561287 @default.
- W4317759512 cites W1940688833 @default.
- W4317759512 cites W1967776969 @default.
- W4317759512 cites W1977379410 @default.
- W4317759512 cites W1993788673 @default.
- W4317759512 cites W2011317507 @default.
- W4317759512 cites W2012801178 @default.
- W4317759512 cites W2018319340 @default.
- W4317759512 cites W2018474923 @default.
- W4317759512 cites W2024130943 @default.
- W4317759512 cites W2036487516 @default.
- W4317759512 cites W2036848448 @default.
- W4317759512 cites W2046089049 @default.
- W4317759512 cites W2064481666 @default.
- W4317759512 cites W2108772785 @default.
- W4317759512 cites W2116370695 @default.
- W4317759512 cites W2126299335 @default.
- W4317759512 cites W2127867032 @default.
- W4317759512 cites W2129693217 @default.
- W4317759512 cites W2144428245 @default.
- W4317759512 cites W2147830477 @default.
- W4317759512 cites W2152007625 @default.
- W4317759512 cites W2163127729 @default.
- W4317759512 cites W2187828640 @default.
- W4317759512 cites W2254134493 @default.
- W4317759512 cites W2417995303 @default.
- W4317759512 cites W2467895892 @default.
- W4317759512 cites W2588933679 @default.
- W4317759512 cites W2739174192 @default.
- W4317759512 cites W2761040354 @default.
- W4317759512 cites W2808829764 @default.
- W4317759512 cites W2898384380 @default.
- W4317759512 cites W2902245307 @default.
- W4317759512 cites W3003919289 @default.
- W4317759512 cites W3012405893 @default.
- W4317759512 cites W3012421327 @default.
- W4317759512 cites W3024045346 @default.
- W4317759512 cites W3048128537 @default.
- W4317759512 cites W3081905990 @default.
- W4317759512 cites W3082108964 @default.
- W4317759512 cites W3091384134 @default.
- W4317759512 cites W3127048941 @default.
- W4317759512 cites W3154803068 @default.
- W4317759512 cites W3175283770 @default.
- W4317759512 cites W3182774911 @default.
- W4317759512 cites W3200368004 @default.
- W4317759512 cites W4249270402 @default.
- W4317759512 doi "https://doi.org/10.1021/acs.jmedchem.2c01996" @default.
- W4317759512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36689364" @default.
- W4317759512 hasPublicationYear "2023" @default.
- W4317759512 type Work @default.
- W4317759512 citedByCount "0" @default.
- W4317759512 crossrefType "journal-article" @default.
- W4317759512 hasAuthorship W4317759512A5013909385 @default.
- W4317759512 hasAuthorship W4317759512A5023065706 @default.
- W4317759512 hasAuthorship W4317759512A5026538320 @default.
- W4317759512 hasAuthorship W4317759512A5039078374 @default.
- W4317759512 hasAuthorship W4317759512A5046632856 @default.
- W4317759512 hasAuthorship W4317759512A5056064654 @default.
- W4317759512 hasAuthorship W4317759512A5056625293 @default.
- W4317759512 hasAuthorship W4317759512A5065595626 @default.
- W4317759512 hasAuthorship W4317759512A5071074966 @default.
- W4317759512 hasAuthorship W4317759512A5082785833 @default.
- W4317759512 hasAuthorship W4317759512A5087023556 @default.
- W4317759512 hasAuthorship W4317759512A5090244756 @default.
- W4317759512 hasConcept C101819947 @default.
- W4317759512 hasConcept C126322002 @default.
- W4317759512 hasConcept C17991360 @default.
- W4317759512 hasConcept C181199279 @default.
- W4317759512 hasConcept C185592680 @default.
- W4317759512 hasConcept C18605011 @default.
- W4317759512 hasConcept C203014093 @default.
- W4317759512 hasConcept C2775967933 @default.
- W4317759512 hasConcept C2776670229 @default.
- W4317759512 hasConcept C2778384902 @default.
- W4317759512 hasConcept C2778754761 @default.
- W4317759512 hasConcept C2780820201 @default.
- W4317759512 hasConcept C2780886150 @default.
- W4317759512 hasConcept C55493867 @default.
- W4317759512 hasConcept C71924100 @default.